Edmund Onuzo, chairman, board of directors, GlaxoSmithKline Consumer Nigeria plc, said the company achieved sustainable performance on its entire healthcare portfolio in 2019 despite challenges faced by manufacturers in the country last year.
Speaking at the 49thAnnual General Meeting (AGM) held
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
